A researcher is one step nearer to demonstrating the potential of a mind molecule referred to as fractalkine to halt and even reverse the consequences of a number of sclerosis and different neurodegenerative ailments. Researchers injected fractalkine into mice with chemically induced MS. They discovered the therapy elevated the variety of new oligodendrocytes — important mind and spinal twine cells that produce myelin in each embryonic and grownup brains — that are broken throughout the MS autoimmune assault.